About
Hayhurst Medical Technologies is a medical device development company based in Kansas City, Missouri, focused on perioperative innovations for surgical oncology. The company is currently developing a novel device for closed-technique hyperthermic intraperitoneal chemotherapy (HIPEC) perfusion, with provisional patent on file.
Currently in discussions with the University of Missouri–Kansas City Innovation Center and Missouri University of Science and Technology regarding engineering and prototype development collaboration. Engaging with the regional medtech ecosystem, including BioSTL, BioGenerator, and Digital Sandbox KC. Preparing for NIH SBIR Phase I submission.
Founder
Joseph L. Hayhurst, MD — physician-founder with prior training in general surgery. Also founder of HippocrAI, an open-source library of AI agents for medical device development.